Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The role of histone deacetylases (HDACs) in human cancer Ropero S; Esteller MMol Oncol 2007[Jun]; 1 (1): 19-25The balance of histone acetylation and deacetylation is an epigenetic layer with a critical role in the regulation of gene expression. Histone acetylation induced by histone acetyl transferases (HATs) is associated with gene transcription, while histone hypoacetylation induced by histone deacetylase (HDAC) activity is associated with gene silencing. Altered expression and mutations of genes that encode HDACs have been linked to tumor development since they both induce the aberrant transcription of key genes regulating important cellular functions such as cell proliferation, cell-cycle regulation and apoptosis. Thus, HDACs are among the most promising therapeutic targets for cancer treatment, and they have inspired researchers to study and develop HDAC inhibitors.|*Transcription, Genetic[MESH]|Acetylation/drug effects[MESH]|Apoptosis/drug effects[MESH]|Cell Cycle/drug effects[MESH]|Enzyme Inhibitors/therapeutic use[MESH]|Histone Acetyltransferases/metabolism[MESH]|Histone Deacetylase Inhibitors[MESH]|Histone Deacetylases/*metabolism[MESH]|Histones/metabolism[MESH]|Humans[MESH]|Neoplasm Proteins/antagonists & inhibitors/*metabolism[MESH]|Neoplasms/drug therapy/*enzymology[MESH] |
